Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan plus cisplatin for recurrent or metastatic head and neck cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-12-07